Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

Publisher： Karger

E-ISSN： 1424-8840|32|1|40-43

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 40-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea

By          

International Journal of Molecular Medicine, Vol. 27, Iss. 4, 2011-01 ,pp. : 525-529

Spandidos Publications

Access to resources Recommend Favorite

Clinical Relevance of the Plasminogen Activator Inhibitor Type1 – a Multifaceted Proteolytic Factor

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 238-244

Karger

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 in kidney pathology (Review)

By      

International Journal of Molecular Medicine, Vol. 31, Iss. 3, 2013-01 ,pp. : 503-510

Spandidos Publications

Access to resources Recommend Favorite

Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue‐type plasminogen activator in trauma patients

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1878-1887

John Wiley & Sons Inc

Access to resources Recommend Favorite